Why the study?
Many patients with mitral regurgitation are not offered surgery due to high perceived surgical risk, driving the development of transcatheter techniques to replicate surgical annuloplasty.
Answers are grounded in this paper and cite their sources.
This review highlights emerging transseptal and transcatheter mitral valve annuloplasty technologies as potential treatment options for patients with mitral regurgitation at high surgical risk.
Annuloplasty is a fundamental component of surgical mitral valve repair, and is employed in nearly 100% of repair operations for both primary and secondary mitral regurgitation (SMR). Developing transcatheter techniques to replicate surgical annuloplasty has been the focus of significant innovation and development in recent years. Since many patients are not offered surgery due to high perceived surgical risk, transcatheter approaches will provide new treatment options. In this manuscript, we review technologies which allow transseptal and transcatheter mitral valve (MV) annuloplasty.
No takes yet. Share an insight, caveat, or question.
Rogers et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: